PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Clinical trials for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) explained in plain language.
Never miss a new study
Get alerted when new PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH) trials appear
Sign up with your email to follow new studies for PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
One pill instead of three: new hope for easing a serious Heart-Lung condition
Disease control CompletedThis study tested if a single pill combining two existing medicines (macitentan and tadalafil) works better for controlling pulmonary arterial hypertension (PAH) than taking the medicines separately. It involved 187 adults with PAH and compared the combination pill against the in…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: PHASE3 • Sponsor: Actelion • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Can simple breathing exercises ease a serious lung condition?
Symptom relief CompletedThis study tested whether a slow-paced breathing exercise, practiced at home using a guided video, could help people with pulmonary arterial hypertension manage their symptoms. Researchers enrolled 42 adults with this lung condition to see if the breathing technique improved shor…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Phase: NA • Sponsor: Ege University • Aim: Symptom relief
Last updated Apr 03, 2026 14:41 UTC
-
Simple scan could sharpen deadly lung disease risk predictions
Knowledge-focused CompletedThis study tested whether a new ultrasound scoring method, called VExUS, could help doctors better assess risk in patients with pulmonary arterial hypertension (PAH). Researchers compared the ultrasound score to the standard risk assessment tools and measurements taken during a h…
Matched conditions: PULMONARY ARTERIAL HYPERTENSION (PAH) (WHO GROUP 1 PH)
Sponsor: Istanbul University - Cerrahpasa • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC